Published in J Am Coll Cardiol on December 01, 2001
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA (2009) 2.90
Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr (2012) 2.14
Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis. Crit Care (2006) 2.03
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci U S A (2005) 1.99
Is readmission to hospital an indicator of poor process of care for patients with heart failure? Qual Saf Health Care (2004) 1.90
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol (2013) 1.66
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.61
Does hospital performance on process measures directly measure high quality care or is it a marker of unmeasured care? Health Serv Res (2007) 1.49
Cardiac remodeling at the population level--risk factors, screening, and outcomes. Nat Rev Cardiol (2011) 1.43
Clinical and genetic modifiers of long-term survival in heart failure. J Am Coll Cardiol (2009) 1.42
Effect of discharge instructions on readmission of hospitalised patients with heart failure: do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care? Qual Saf Health Care (2006) 1.41
Clinical implications of an accurate problem list on heart failure treatment. J Gen Intern Med (2005) 1.38
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart (2005) 1.29
Heart failure and palliative care: implications in practice. J Palliat Med (2009) 1.28
Just-in-time evidence-based e-mail "reminders" in home health care: impact on patient outcomes. Health Serv Res (2005) 1.23
Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med (2005) 1.23
The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. J Extra Corpor Technol (2010) 1.19
Revascularization in patients with heart failure. CMAJ (2006) 1.18
Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev (2004) 1.18
The Heart Failure Adherence and Retention Trial (HART): design and rationale. Am Heart J (2008) 1.16
Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci U S A (2006) 1.13
Pharmacogenetics of beta-blockers. Pharmacotherapy (2007) 1.13
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther (2005) 1.13
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol (2010) 1.09
Adaptive postprocessing techniques for myocardial tissue tracking with displacement-encoded MR imaging. Radiology (2008) 1.07
Nitroxyl gets to the heart of the matter. Proc Natl Acad Sci U S A (2003) 1.07
Management of diastolic heart failure in older adults. BMJ (2004) 1.07
Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag (2008) 1.05
Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Fail Rev (2012) 1.04
The African-American Heart Failure Trial: background, rationale and significance. J Natl Med Assoc (2002) 1.02
Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population. BMC Cardiovasc Disord (2007) 1.02
Improved survival after heart failure: a community-based perspective. J Am Heart Assoc (2013) 1.00
Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000. Clin Res Cardiol (2006) 0.99
Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA). Circulation (2012) 0.98
Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J (2004) 0.95
Right ventricular cardiomyocyte apoptosis in patients with acute myocardial infarction of the left ventricular wall. Am J Cardiol (2008) 0.95
Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. J Clin Pathol (2003) 0.95
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med (2010) 0.93
Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy. Heart Vessels (2013) 0.93
Secular trends of heart failure among US male physicians. Am Heart J (2007) 0.92
Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev (2014) 0.92
Device monitoring strategies in acute heart failure syndromes. Heart Fail Rev (2011) 0.91
Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respir Med (2013) 0.87
Treatment of heart failure in Dutch general practice. BMC Fam Pract (2006) 0.87
Cardiac causes of pulmonary arterial hypertension: assessment with multidetector CT. Eur Radiol (2009) 0.87
Brain natriuretic peptide and optimal management of heart failure. J Zhejiang Univ Sci B (2005) 0.86
Trends in the medical management of patients with heart failure. J Clin Med Res (2013) 0.86
Diabetic cardiovascular disease: getting to the heart of the matter. J Cardiovasc Transl Res (2012) 0.85
When comorbidity, aging, and complexity of primary care meet: development and validation of the Geriatric CompleXity of Care Index. J Am Geriatr Soc (2013) 0.85
A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study. J Cardiovasc Nurs (2012) 0.85
NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS One (2012) 0.84
Low-sodium diet self-management intervention in heart failure: pilot study results. Eur J Cardiovasc Nurs (2012) 0.84
Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J (2005) 0.84
Association between adiponectin and heart failure risk in the physicians' health study. Obesity (Silver Spring) (2013) 0.83
Treatment of systemic hypertension. Am J Cardiovasc Dis (2012) 0.83
Management of coronary artery disease in a Tertiary Care Hospital. J Basic Clin Pharm (2013) 0.83
Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics. Contemp Clin Trials (2013) 0.83
Heart failure in the Middle East. Curr Cardiol Rev (2013) 0.83
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction. Vasc Health Risk Manag (2007) 0.82
A clinical study of pattern and factors affecting outcome in Nigerian patients with advanced heart failure. Cardiovasc J Afr (2007) 0.82
Adiposity and incident heart failure in older adults: the cardiovascular health study. Obesity (Silver Spring) (2011) 0.82
Exercise Training for Heart Failure Patients with and without Systolic Dysfunction: An Evidence-Based Analysis of How Patients Benefit. Cardiol Res Pract (2010) 0.81
Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function. J Card Fail (2009) 0.81
Diagnostic accuracy of tissue Doppler echocardiography for patients with acute heart failure. Heart (2006) 0.80
Cardiorenal syndrome caused by heart failure with preserved ejection fraction. Int J Nephrol (2011) 0.80
Left Ventricular Assist Devices as Destination Therapy for End-stage Heart Failure. Curr Treat Options Cardiovasc Med (2004) 0.80
Cardiac dysfunction after cancer treatment. Tex Heart Inst J (2011) 0.80
Walking and running produce similar reductions in cause-specific disease mortality in hypertensives. Hypertension (2013) 0.80
Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure. Can J Cardiol (2009) 0.80
Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Eur J Clin Pharmacol (2005) 0.79
Pharmacokinetics and pharmacodynamics of beta blockers in heart failure. Heart Fail Rev (2004) 0.79
Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen. Indian J Pharm Sci (2013) 0.79
N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study. Arch Intern Med (2007) 0.79
Heart failure patients' perceptions on nutrition and dietary adherence. Eur J Cardiovasc Nurs (2009) 0.79
Hibernation and heart failure. Heart (2004) 0.79
Regional variations in palliative care: do cardiologists follow guidelines? J Palliat Med (2010) 0.79
Pharmacogenetic profiling in the treatment of heart disease. Transl Res (2009) 0.79
B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure. Heart Fail Rev (2003) 0.79
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure. Cardiol Res Pract (2016) 0.78
Appraising hospital performance by using the JCHAO/CMS quality measures in Southern Italy. PLoS One (2012) 0.78
Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure. J Card Fail (2007) 0.78
Dietary sodium restriction below 2 g per day predicted shorter event-free survival in patients with mild heart failure. Eur J Cardiovasc Nurs (2013) 0.78
Heart failure with a normal left ventricular ejection fraction: diastolic heart failure. Trans Am Clin Climatol Assoc (2008) 0.78
Population based study on the prevalence of the stages of heart failure. Heart (2006) 0.78
Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction. Braz J Med Biol Res (2013) 0.78
Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review. Int J Angiol (2010) 0.78
Dose-dependent relationship of physical and depressive symptoms with health-related quality of life in patients with heart failure. Eur J Cardiovasc Nurs (2013) 0.78
Cardiac asthma in elderly patients: incidence, clinical presentation and outcome. BMC Cardiovasc Disord (2007) 0.78
Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function. Heart (2005) 0.78
Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure. J Transl Med (2015) 0.77
The effect of antihypertensive drugs on endothelial function as assessed by flow-mediated vasodilation in hypertensive patients. Int J Vasc Med (2012) 0.77
The Effect of Tele-Monitoring on Exercise Training Adherence, Functional Capacity, Quality of Life and Glycemic Control in Patients With Type II Diabetes. J Sports Sci Med (2012) 0.77
Carvedilol in the treatment of elderly patients with chronic heart failure. Clin Interv Aging (2008) 0.77
Hypertension and concomitant diseases: a guide for evidence-based therapy. J Natl Med Assoc (2004) 0.77
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med (1992) 17.33
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol (2000) 16.47
The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills. J Gen Intern Med (1995) 15.10
Bacterial adherence in oral microbial ecology. Annu Rev Microbiol (1975) 11.44
Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19
Inadequate functional health literacy among patients at two public hospitals. JAMA (1995) 10.12
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Relationship of functional health literacy to patients' knowledge of their chronic disease. A study of patients with hypertension and diabetes. Arch Intern Med (1998) 8.85
Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med (1994) 8.80
Health literacy among Medicare enrollees in a managed care organization. JAMA (1999) 8.63
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Coronary plaque disruption. Circulation (1995) 8.04
Idiopathic dilated cardiomyopathy. N Engl J Med (1994) 7.74
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
Inadequate literacy is a barrier to asthma knowledge and self-care. Chest (1998) 6.93
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science (1972) 6.80
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med (1984) 6.74
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 6.58
Synthesis of insoluble dextran and its significance in the formation of gelatinous deposits by plaque-forming streptococci. Arch Oral Biol (1968) 6.55
Dextran-induced agglutination of Streptococcus mutans, and its potential role in the formation of microbial dental plaques. J Bacteriol (1969) 6.44
M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun (1972) 6.29
Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med (1991) 6.16
Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces. Infect Immun (1978) 5.73
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
Attachment of Bacteroides melaninogenicus subsp. asaccharolyticus to oral surfaces and its possible role in colonization of the mouth and of periodontal pockets. Infect Immun (1978) 5.20
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation (2000) 5.15
Left ventricular volumes and ejection fraction by echocardiography. Circulation (1971) 5.00
Interbacterial aggregation of plaque bacteria. Arch Oral Biol (1970) 4.98
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Dental caries. Annu Rev Med (1975) 4.89
Patient preferences for colorectal cancer screening. J Fam Pract (1997) 4.55
Studies of the cultivable flora of normal human feces. Antonie Van Leeuwenhoek (1966) 4.47
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32
Dental caries and alveolar bone loss in gnotobiotic rats infected with capsule forming streptococci of human origin. Arch Oral Biol (1966) 4.29
Shame and health literacy: the unspoken connection. Patient Educ Couns (1996) 4.29
The on-call experience of interns in internal medicine. Medical Education Task Force of Henry Ford Hospital. Arch Intern Med (1990) 4.26
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
Adherence as an ecological determinant for streptococci in the human mouth. Arch Oral Biol (1971) 4.18
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Synthesis of extracellular dextran by cariogenic bacteria and its presence in human dental plaque. Arch Oral Biol (1967) 3.99
Laser capture microdissection: molecular analysis of tissue. Science (1997) 3.93
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med (2001) 3.80
On the formation of dental plaques. J Periodontol (1973) 3.77
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
Parameters affecting the adherence and tissue tropisms of Streptococcus pyogenes. Infect Immun (1974) 3.73
Proportional distribution and relative adherence of Streptococcus miteor (mitis) on various surfaces in the human oral cavity. Infect Immun (1972) 3.70